All In Biotech

Free tool

FAERS Monitor: Fluoxetine Hydrochloride

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 202133 or its brand name (Fluoxetine Hydrochloride, Fluoxetine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

13,085

Serious

9,897

76% of reports

Hospitalization

4,269

Death reported

1,521

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • headache934
  • drug ineffective876
  • off label use849
  • fatigue793
  • drug interaction789
  • nausea749
  • toxicity to various agents730
  • intentional overdose684
  • dizziness657
  • dyspnoea645
  • diarrhoea620
  • suicide attempt581
  • fall564
  • vomiting548
  • somnolence479

Reports by year received

View as table
YearReports
2004148
2005118
2006100
2007124
2008163
2009107
2010107
2011231
2012224
2013212
2014266
2015383
2016293
2017495
2018584
2019637
2020515
2021714
20221,352
20231,496
20241,738
20251,678
20261,400

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,041,074 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
intentional overdoseSignal68417.316.110,419
suicide attemptSignal58115.514.37,837
drug interactionSignal7898.07.54,861
toxicity to various agentsSignal7307.06.53,751
somnolenceSignal4793.83.51,006
fallSignal5642.72.5624
headacheSignal9342.42.3781
dizzinessSignal6572.12.0396
vomiting5481.91.7228
dyspnoea6451.81.7250
fatigue7931.61.5204
off label use8491.61.5177
diarrhoea6201.51.4122
nausea7491.51.4139
drug ineffective8761.11.04

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.